Speak with an expert
Your needs are unique, we are here to help you determine the best solution to propel your work forward. Get in touch with our experts to find out more about our services that enables breakthroughs.
Do you need technical assistance? Contact support
April 28, 2022
Back in the Saddle at the AACR
This year, after two long years of convening virtually, it was great to see so many unite in the city of New Orleans for #AACR2022.
April 07, 2022
Ultivue Announces Co-Marketing and Co-Development Collaboration with Paige
Ultivue, an industry leader in multiplexing tools for tissue biomarker analysis, and Paige, the global leader in AI-based diagnostic software in pathology, today announced a partnership to collaborate on the co-development and co-marketing of AI-powered spatial immunophenotype capabilities to pharmaceutical and research customers.
April 06, 2022
Ultivue Announces Multiple Events for AACR 2022
Ultivue today announced that data from its FlexVUE™ formatting for panel design and its newest mouse panel offering for multiplex immunofluorescence (mIF) and spatially resolved biomarker analysis will be presented at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2022.
March 30, 2022
Better Laid Plans of Mice and Men
Adapted from a line in “Ode to a Mouse” from fellow countryman Robert Burns, the phrase, “the best-laid plans of mice and men often go awry”, indicate that no matter how carefully a project is planned, something may still go wrong with it unfortunately speaks to the reality of clinical trials for novel therapeutics, with approximately only 11% of drugs that begin phase I clinical trials eventually being licensed.
March 29, 2022
Keen Eye and Ultivue announce collabor-ative agreement
Keen Eye, a leading AI company in digital pathology for clinical research, and Ultivue announced a collaborative agreement to promote multiplexed immunofluorescence (mIF) assays and novel AI applications to unlock spatial analysis in clinical research.
March 28, 2022
The Much-Welcomed Return of In-Person Conferences
It is clear that “zoom fatigue” has set in, and some of the novelty of virtual conferences has worn off in the past year; having said that, they are likely here to stay, even as in-person events return with hybrid events in 2022.
March 15, 2022
Ultivue announces co-marketing agreement with Sirona DX
Ultivue and Sirona Dx, a technical contract research organization (CRO), providing advanced, single cell proteomics and genomics services to accelerate the pace of immunotherapy and targeted therapy development, announced a co-marketing agreement to deliver tissue-based spatial multiplexed immuno-phenotyping solutions for translational research groups and Biopharma.
March 09, 2022
Unique spatial AI-powered imaging solutions for translational medicine
Ultivue and Aignostics GmbH, a global leader in Artificial Intelligence (AI) powered precision diagnostics focused on pathology to assist with research, clinical trials and CDx development, announced a partnership to collaborate on the co-development of AI-powered spatial multiplexed immunophenotype solutions for translational research groups and Biopharma.
February 23, 2022
The Crossroads Between Immuno-Oncology and Digital Pathology
It’s clearly a very timely discussion with many recent articles reviewing the complexities of the tumor microenvironment and overall tumor heterogeneity that have been implicated in late-stage clinical failures, underscoring an urgent need for tests that accurately predict response to the growing number of available therapies.